by Steven F. Pockrass and Alfred B. Robinson Jr., Esqs., Ogletree Deakins
The U.S. Supreme Court in June ruled that pharmaceutical sales representatives are indeed outside salespeople under the terms of the Fair Labor Standards Act () in a case that could have far-reaching effects on other wage-and-hour issues.
The ruling in Christopher v. SmithKline Beecham Corp. (No. 11-204, U.S. Sup. Ct., 2012) means that pharmaceutical sales representatives are exempt from the FLSA’s overtime compensation requirements. Although a critical decision for the pharmaceutical industry, the case is more broadly significant because it provides insight into the weight the Supreme Court would give to agency views of the laws they enforce.
Unusual kinds of ‘sales’
Pharmaceutical companies like SmithKline Beecham promote their drugs to physicians through a process in which sales representatives try to persuade physicians to write prescriptions...(register to read more)
- Feds probe pay at restaurants in Los Angeles, San Francisco
- Thinking about shrugging off employee suit? Then think about writing a really big check
- What should we do? If employee took all her comp time, she couldn't do her job
- Payroll records: Know exempt, nonexempt timekeeping requirements
- The auditors are coming ... the auditors are coming